Skip to main content

Together we are beating cancer

Donate now

Analysis

Showing 12 out of 2503 results
Up and running - how to speed up clinical trials

The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could... The UK is ideally suited for early phase oncology trials, so is it possible to speed up set-up time? Sharan Sandhu tells us how we could...

by Phil Prime | Analysis | 15 December 2025

15 December 2025

Woman waiting in hospital waiting room

Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer Get the latest updates and analysis on NHS cancer waiting times in England, and learn what it means for people affected by cancer

by Sophia Lowes, Momoko Bowles | Analysis | 11 December 2025

11 December 2025

The Cancer Research UK team outside the Senedd.

A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion. A significant milestone for our Smokefree UK campaign, as Members of the Senedd (MSs) voted in favour of applying the Tobacco and Vapes Bill to Wales through a legislative consent motion.

by Cancer Research UK | Analysis | 10 December 2025

10 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

A close up shot of a person putting the bowel cancer test sample in the sample holder to send off by mail for testing.
  • Health & Medicine
  • Policy & Insight

How are cancer screening programmes decided in the UK?

The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided? The UK has national screening programmes for cervical, bowel and breast cancer, with targeted lung screening being implemented in some regions. But how are they all decided?

by Cancer Research UK | Analysis | 21 November 2025

21 November 2025

Hand in a glove holding a scalpel.

Cancer surgery has been around for thousands of years. Now, we're bringing it into the 21st century with light-up dyes, lasers and robots. Cancer surgery has been around for thousands of years. Now, we're bringing it into the 21st century with light-up dyes, lasers and robots.

by Nisharnthi Duggan | Analysis | 19 November 2025

19 November 2025

A plastic bag connected to a small machine.

Our researchers are developing a breath test that could help diagnose stomach cancer sooner, so people get treated faster. Our researchers are developing a breath test that could help diagnose stomach cancer sooner, so people get treated faster.

by Nisharnthi Duggan | Analysis | 13 November 2025

13 November 2025

Data science column

LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy... LLMs are impressive yet they also pose a threat to science. The first column in our new series on data science gets into the dichotomy...

by Cancer Research UK | Analysis | 11 November 2025

11 November 2025

A microscopic image showing a tumour sample with different types of cells in different colours. Macrophages (red) are producing HO-1 near blood vessels (green) to keep T cells out of tumour tissue. Many of the blue cells in this image are cancer cells. There are small pockets of T cells highlighted in magenta.

KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects. KCL-HO-1i, a new type of chemotherapy "companion drug" that can be taken as a daily pill, could pave the way to more effective cancer treatments with fewer side effects.

by Tim Gunn | Analysis | 4 November 2025

4 November 2025

A thin yellow patch

With our funding, PhD student Marah Alassaf is developing an “electronic skin” patch designed to make breast cancer testing more comfortable and accessible. With our funding, PhD student Marah Alassaf is developing an “electronic skin” patch designed to make breast cancer testing more comfortable and accessible.

by Nisharnthi Duggan | Analysis | 21 October 2025

21 October 2025